Current and Future Antiviral Research
A virus mutates, an antiviral loses potency, and a new outbreak finds us one step behind. This cycle has defined antiviral medicine for decades. Now, a convergence of broad-spectrum drug design, host-targeted therapies, AI-driven discovery, nanotechnology, and CRISPR...
VRS Successfully Maintains ISO 9001 Certification
Virology Research Services is pleased to announce that we have successfully maintained our ISO 9001:2015 certification following our latest annual audit. This recertification confirms the continued strength and effectiveness of our Quality Management System (QMS). In...
New to Our Assay Portfolio: Human Metapneumovirus (hMPV)
VRS now offers validated antiviral and neutralisation assay services for Human Metapneumovirus (hMPV). hMPV is a leading cause of acute respiratory tract infections worldwide, particularly in young children, the elderly, and immunocompromised individuals. Despite its...
Viral Zoonotic Threats
Ancient Mesopotamian lawmakers wrote penalties for owners of rabid dogs around 1930 BC. In 1918, an influenza virus that likely originated in birds or pigs killed an estimated 50 million people, more than the combat deaths of World War I. In the 1920s, HIV-1 crossed...Page 1 of 33